ReviewFrontiers in pharmacology2021

Efficacy and Safety of Rifaximin Versus Placebo or Other Active Drugs in Critical ill Patients With Hepatic Encephalopathy.

Xianghui Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.